U.S. Markets closed

MyMD Pharmaceuticals, Inc. (MYMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.75-0.09 (-1.54%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.84
Open5.68
Bid4.56 x 1100
Ask5.75 x 900
Day's Range5.61 - 5.83
52 Week Range3.30 - 13.94
Volume928,424
Avg. Volume423,919
Market Cap213.528M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    MyMD Pharmaceuticals Set to Join Russell Microcap® Index

    MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution effective after the US market opens on June 28, according to a preliminary list of additions posted June 4.

  • Business Wire

    MyMD Pharmaceuticals Appoints David Rini, Professor at the Johns Hopkins School of Medicine, to Scientific Advisory Board

    MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, announced today that it has appointed David Rini to the Company’s Scientific Advisory Board.

  • Business Wire

    MyMD Pharmaceuticals Schedules Business Update Conference Call

    MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, announced it will host a conference call at 4:15 p.m. Eastern time on Monday, May 17th to provide an update on its clinical and drug development plan.